cap today Archives - The Dark Intelligence Group

TAG:

cap today

LabCorp, Quest Talk about Medicare Lab Price Cuts

By Robert Michel | From the Volume XXIV No. 11 – August 7, 2017 Issue

CEO SUMMARY: In an effort to forestall CMS’ efforts to implement the PAMA final rule on market price reporting, Laboratory Corporation of America and Quest Diagnostics are meeting with members of Congress, officials in the administration, and the new leadership of CMS. During recent con…

Lean Used to Lay Groundwork for Lab’s 15189 Accreditation

By Joseph Burns | From the Volume XXI No. 2 – February 3, 2014 Issue

CEO SUMMARY: Henry Ford Health System’s laboratory organization has become first in the nation to have all its laboratory sites “standardized under one source of leadership” and accredited to the standards of ISO 15189: Medical Laboratories. The journey to achieve this current state…

All-Star Vitamin D Panel Looks at Lab Challenges

By Robert Michel | From the Volume XVI No. 10 – July 20, 2009 Issue

CEO SUMMARY: Need proof that the issues surrounding today’s Vitamin 25(OH) D are of keen interest to laboratory professionals? Not only did the EXECUTIVE WAR COLLEGE’S in depth sessions on Vitamin D draw a large audience and enthusiastic participation by attendees, but within…

Multi-Modality Diagnosis Heading for Lab Medicine

By Robert Michel | From the Volume XV No. 16 – December 01, 2008 Issue

CEO Summary: At the upcoming Molecular Summit in Philadelphia on February 10-11, 2009, pathologists, molecular imaging experts, and informaticians will share the latest developments on the integration of in vivo (imaging) and in vitro (pathology) diagnost…

New Rules to Boost Cancer Test Accuracy

By Robert Michel | From the Volume XVI No. 3 – February 19, 2007 Issue

CEO SUMMARY: Recent developments in breast cancer testing are leading to changes in pathology. Oncologists and pathologists have issued new guidelines regarding HER2 testing and new research suggests changes may be coming for estrogen-receptor testing as well. For the first time, the new …

Pathologist-Entrepreneurs Offer New Lab Automation

By Robert Michel | From the Volume XIII No. 11 – August 14, 2006 Issue

CEO SUMMARY: Since October 2003, the core laboratory of Detroit Medical Center University Laboratories has operated with a home-grown total laboratory automation (TLA) system. The 100-foot automated line currently connects to 11 instruments and the hardware cost only $200,000 to build and…

“April 5, 2004 Intelligence: Late Breaking Lab News”

By Robert Michel | From the Volume XI No. 5 – April 5, 2004 Issue

There’s a new national lab company ready to compete. This week American Esoterix Laboratories, Inc. (AEL) announced it was open and ready for business. Based in Brentwood, Tennessee, it has already completed two lab acquisitions (ThromboCare Laboratories and …

Path Trends For 2002 Show Future Direction

By Robert Michel | From the Volume IX No. 1 – January 7, 2002 Issue

CEO SUMMARY: Even as pressures to squeeze costs and consolidate within the pathology profession ease, a different set of market trends is exerting influence. Collectively, these trends portend the end of the small pathology group’s dominance of its local healthcare marketplace. It will …

Northwestern Hospital Laboratory Supports Reduced Infection Rate

By Robert Michel | From the Volume VIII No. 11 – August 13, 2001 Issue

THIS MONTH, ONE OF THE NATION’S most unique and effective nosocomial infection programs completes its seventh year of operation at Northwestern Memorial Hospital in Chicago. This one-of-a-kind infection control effort is organized around the laboratory—specifically, in-house mo…

“March 6, 2000 Intelligence: Late Breaking Lab News”

By Robert Michel | From the Volume VII No. 4 – March 6, 2000 Issue

Interesting things are afoot at Esoterix, Inc., the Austin, Texas-based parent company for six specialty laboratories. President and CEO Charles L Dufesche, M.D. recently left. The new CEO is James McClintic. Esoterix has plans to become a public company and has been shopping its IPO…

Volume XXVII No. 9 – June 22, 2020

THE NEWS ON THE SEROLOGICAL TEST FRONT is discouraging, even bleak, as THE DARK REPORT analyzes the outcome of the FDA’s own review of 11 tests previously listed as marketable. Only three tests passed the review, and yet a quality control expert consulted by THE DARK REPORT has dim views of the FDA’s testing operation, leading to even more doubts. Also, health insurers are scraping away at mandated COVID-19 test reimbursements, leaving lab revenues once again at their mercy.

See the full table of contents

How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Need A Group Membership? Company Discounts are Available!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

Topics

Visit The Dark Library